These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28158205)
1. Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1. Zhou C; Wu F; Lu L; Wei L; Pai E; Yao Y; Song Y PLoS One; 2017; 12(2):e0170301. PubMed ID: 28158205 [TBL] [Abstract][Full Text] [Related]
3. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking. Zhou C; Kang D; Xu Y; Zhang L; Zha X Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896 [TBL] [Abstract][Full Text] [Related]
5. 3-(Piperidin-4-ylmethoxy)pyridine Containing Compounds Are Potent Inhibitors of Lysine Specific Demethylase 1. Wu F; Zhou C; Yao Y; Wei L; Feng Z; Deng L; Song Y J Med Chem; 2016 Jan; 59(1):253-263. PubMed ID: 26652247 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures. Ota Y; Kakizawa T; Itoh Y; Suzuki T Molecules; 2018 May; 23(5):. PubMed ID: 29734782 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors. Ota Y; Miyamura S; Araki M; Itoh Y; Yasuda S; Masuda M; Taniguchi T; Sowa Y; Sakai T; Itami K; Yamaguchi J; Suzuki T Bioorg Med Chem; 2018 Feb; 26(3):775-785. PubMed ID: 29331452 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A. Vianello P; Botrugno OA; Cappa A; Ciossani G; Dessanti P; Mai A; Mattevi A; Meroni G; Minucci S; Thaler F; Tortorici M; Trifiró P; Valente S; Villa M; Varasi M; Mercurio C Eur J Med Chem; 2014 Oct; 86():352-63. PubMed ID: 25173853 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation. Schulz-Fincke J; Hau M; Barth J; Robaa D; Willmann D; Kürner A; Haas J; Greve G; Haydn T; Fulda S; Lübbert M; Lüdeke S; Berg T; Sippl W; Schüle R; Jung M Eur J Med Chem; 2018 Jan; 144():52-67. PubMed ID: 29247860 [TBL] [Abstract][Full Text] [Related]
11. Lysine-specific demethylase 1-mediated demethylation of histone H3 lysine 9 contributes to interleukin 1β-induced microsomal prostaglandin E synthase 1 expression in human osteoarthritic chondrocytes. El Mansouri FE; Nebbaki SS; Kapoor M; Afif H; Martel-Pelletier J; Pelletier JP; Benderdour M; Fahmi H Arthritis Res Ther; 2014 May; 16(3):R113. PubMed ID: 24886859 [TBL] [Abstract][Full Text] [Related]
12. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening. Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512 [TBL] [Abstract][Full Text] [Related]
13. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines. Murray-Stewart T; Woster PM; Casero RA Amino Acids; 2014 Mar; 46(3):585-94. PubMed ID: 23508577 [TBL] [Abstract][Full Text] [Related]
14. Nucleosome Binding by the Lysine Specific Demethylase 1 (LSD1) Enzyme Enables Histone H3 Demethylation. Dhall A; Shelton PMM; Delachat AM; Leonen CJA; Fierz B; Chatterjee C Biochemistry; 2020 Jul; 59(27):2479-2483. PubMed ID: 32567837 [TBL] [Abstract][Full Text] [Related]
15. Tying up tranylcypromine: Novel selective histone lysine specific demethylase 1 (LSD1) inhibitors. Ji YY; Lin SD; Wang YJ; Su MB; Zhang W; Gunosewoyo H; Yang F; Li J; Tang J; Zhou YB; Yu LF Eur J Med Chem; 2017 Dec; 141():101-112. PubMed ID: 29031059 [TBL] [Abstract][Full Text] [Related]
16. Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A. Pieroni M; Annunziato G; Azzali E; Dessanti P; Mercurio C; Meroni G; Trifiró P; Vianello P; Villa M; Beato C; Varasi M; Costantino G Eur J Med Chem; 2015 Mar; 92():377-86. PubMed ID: 25585008 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. Culhane JC; Wang D; Yen PM; Cole PA J Am Chem Soc; 2010 Mar; 132(9):3164-76. PubMed ID: 20148560 [TBL] [Abstract][Full Text] [Related]
18. LSD1: more than demethylation of histone lysine residues. Perillo B; Tramontano A; Pezone A; Migliaccio A Exp Mol Med; 2020 Dec; 52(12):1936-1947. PubMed ID: 33318631 [TBL] [Abstract][Full Text] [Related]
19. Novel Tranylcypromine/Hydroxylcinnamic Acid Hybrids as Lysine-Specific Demethylase 1 Inhibitors with Potent Antitumor Activity. Han Y; Wu C; Lv H; Liu N; Deng H Chem Pharm Bull (Tokyo); 2015; 63(11):882-9. PubMed ID: 26521853 [TBL] [Abstract][Full Text] [Related]
20. Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts. Valente S; Rodriguez V; Mercurio C; Vianello P; Saponara B; Cirilli R; Ciossani G; Labella D; Marrocco B; Monaldi D; Ruoppolo G; Tilset M; Botrugno OA; Dessanti P; Minucci S; Mattevi A; Varasi M; Mai A Eur J Med Chem; 2015 Apr; 94():163-74. PubMed ID: 25768700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]